EUTM file information
018474986
Tris PHARMA
May 18, 2021
Trademark Summary
The trademark Tris PHARMA was filed by Tris Pharma, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on June 16, 2021, and received one opposition filed on August 2, 2021 by Mylan Inc. on Likelihood of confusion. the opponent was represented by Koch, Manuela and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued August 2, 2021
The application was filed in English, and English was also language of all opposition proceedings (Italian was selected as the second language).
Goods And Services
- The mark was filed in class 5 with following description of goods:
- Pharmaceutical preparations, namely, beta-Hydroxy beta-methylglutaryl-CoA (HMG-CoA) reductase inhibitors used to lower LDL cholesterol and to treat hypertriglyceridemia as an adjunct to diet, cholesterol lowering medications
- Pharmaceutical preparations that act as central nervous system stimulants
- Pharmaceutical preparations, namely, neuromodulators for treatment of psychiatric disorders and disorders related to attention-deficit hyperactivity disorder
- Pharmaceutical preparations for the treatment of attention-deficit hyperactivity disorder (ADHD)
- Liquid oral pharmaceutical preparations for the treatment of attention-deficit hyperactivity disorder (ADHD)
- Solid pharmaceutical preparations for the treatment of attention-deficit hyperactivity disorder (ADHD)
- Pharmaceutical preparations for the treatment of narcolepsy
- Pharmaceutical preparations for the treatment of chronic lung disease
- Pharmaceutical preparations for the treatment of colds
- Pharmaceutical preparations for the treatment of coughs
- Extended release liquid for the treatment of coughs
- Pharmaceutical preparations for the treatment of upper respiratory symptoms
- Pharmaceutical preparations for the treatment of pain.
- The mark was filed in class 42 with Scientific research and development for pharmaceuticals, neutraceuticals, drug delivery products and biomedical products and raw materials and components used in pharmaceuticals and testing for others of pharmaceuticals, neutraceuticals, drug delivery products and biomedical products..
